vs
Side-by-side financial comparison of Ponce Financial Group, Inc. (PDLB) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $31.4M, roughly 1.8× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -83.0%, a 119.3% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs 36.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 23.7%).
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
PDLB vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.4M | $57.3M |
| Net Profit | $10.1M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 43.6% | -82.2% |
| Net Margin | 36.3% | -83.0% |
| Revenue YoY | 37.6% | 36.9% |
| Net Profit YoY | 245.6% | -9.6% |
| EPS (diluted) | $0.43 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $31.4M | $57.3M | ||
| Q3 25 | $26.7M | $51.3M | ||
| Q2 25 | $26.5M | $48.5M | ||
| Q1 25 | $24.6M | $32.7M | ||
| Q4 24 | $22.8M | $41.8M | ||
| Q3 24 | $20.2M | $33.3M | ||
| Q2 24 | $20.2M | $29.1M | ||
| Q1 24 | $20.5M | $26.0M |
| Q4 25 | $10.1M | $-47.5M | ||
| Q3 25 | $6.5M | $-52.9M | ||
| Q2 25 | $6.1M | $-46.6M | ||
| Q1 25 | $6.0M | $-49.5M | ||
| Q4 24 | $2.9M | $-43.3M | ||
| Q3 24 | $2.4M | $-43.6M | ||
| Q2 24 | $3.2M | $-32.3M | ||
| Q1 24 | $2.4M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 43.6% | -82.2% | ||
| Q3 25 | 32.8% | -102.6% | ||
| Q2 25 | 30.2% | -93.4% | ||
| Q1 25 | 32.5% | -143.7% | ||
| Q4 24 | 19.6% | -98.6% | ||
| Q3 24 | 15.2% | -132.0% | ||
| Q2 24 | 21.8% | -139.2% | ||
| Q1 24 | 18.3% | -538.7% |
| Q4 25 | 36.3% | -83.0% | ||
| Q3 25 | 24.3% | -103.1% | ||
| Q2 25 | 23.0% | -96.1% | ||
| Q1 25 | 24.2% | -151.4% | ||
| Q4 24 | 14.1% | -103.6% | ||
| Q3 24 | 12.1% | -131.2% | ||
| Q2 24 | 15.8% | -110.9% | ||
| Q1 24 | 11.8% | -544.4% |
| Q4 25 | $0.43 | $-0.73 | ||
| Q3 25 | $0.27 | $-0.82 | ||
| Q2 25 | $0.25 | $-0.75 | ||
| Q1 25 | $0.25 | $-0.81 | ||
| Q4 24 | $0.11 | $-0.71 | ||
| Q3 24 | $0.10 | $-0.73 | ||
| Q2 24 | $0.14 | $-0.55 | ||
| Q1 24 | $0.11 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $126.2M | $388.9M |
| Total DebtLower is stronger | $596.1M | — |
| Stockholders' EquityBook value | $541.5M | $139.1M |
| Total Assets | $3.2B | $480.2M |
| Debt / EquityLower = less leverage | 1.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.2M | $388.9M | ||
| Q3 25 | $146.6M | $416.1M | ||
| Q2 25 | $126.6M | $291.0M | ||
| Q1 25 | $129.9M | $314.5M | ||
| Q4 24 | $139.8M | $320.6M | ||
| Q3 24 | $155.8M | $298.4M | ||
| Q2 24 | $103.2M | $319.1M | ||
| Q1 24 | $134.7M | $201.2M |
| Q4 25 | $596.1M | — | ||
| Q3 25 | $521.1M | — | ||
| Q2 25 | $536.1M | — | ||
| Q1 25 | $521.1M | — | ||
| Q4 24 | $596.1M | — | ||
| Q3 24 | $580.4M | — | ||
| Q2 24 | $680.4M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $541.5M | $139.1M | ||
| Q3 25 | $529.8M | $148.8M | ||
| Q2 25 | $521.1M | $-11.9M | ||
| Q1 25 | $513.9M | $18.9M | ||
| Q4 24 | $505.5M | $21.7M | ||
| Q3 24 | $504.6M | $11.2M | ||
| Q2 24 | $497.7M | $39.3M | ||
| Q1 24 | $493.7M | $61.6M |
| Q4 25 | $3.2B | $480.2M | ||
| Q3 25 | $3.2B | $506.9M | ||
| Q2 25 | $3.2B | $372.7M | ||
| Q1 25 | $3.1B | $386.7M | ||
| Q4 24 | $3.0B | $392.3M | ||
| Q3 24 | $3.0B | $363.6M | ||
| Q2 24 | $2.8B | $381.8M | ||
| Q1 24 | $2.8B | $258.7M |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.98× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.6M | $-25.4M |
| Free Cash FlowOCF − Capex | $54.6M | — |
| FCF MarginFCF / Revenue | 173.9% | — |
| Capex IntensityCapex / Revenue | 3.1% | — |
| Cash ConversionOCF / Net Profit | 5.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | $74.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.6M | $-25.4M | ||
| Q3 25 | $1.4M | $-26.6M | ||
| Q2 25 | $6.2M | $-23.3M | ||
| Q1 25 | $13.1M | $-40.4M | ||
| Q4 24 | $7.2M | $-18.8M | ||
| Q3 24 | $-14.6M | $-25.2M | ||
| Q2 24 | $-2.6M | $-29.1M | ||
| Q1 24 | $1.5M | $-40.7M |
| Q4 25 | $54.6M | — | ||
| Q3 25 | $786.0K | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $-15.0M | — | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-315.0K | — |
| Q4 25 | 173.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 22.4% | — | ||
| Q1 25 | 52.6% | — | ||
| Q4 24 | 19.7% | — | ||
| Q3 24 | -74.1% | — | ||
| Q2 24 | -13.0% | — | ||
| Q1 24 | -1.5% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 8.7% | — |
| Q4 25 | 5.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 2.46× | — | ||
| Q3 24 | -5.99× | — | ||
| Q2 24 | -0.80× | — | ||
| Q1 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
